Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the VISITAG SURPOINT™ Module With External Processing Unit (EPU) When Used With the THERMOCOOL SMARTTOUCH® SF and the THERMOCOOL SMARTTOUCH® Catheters for Pulmonary Vein Isolation (PVI) (SURPOINT COA)

NCT03624881 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT03624881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03624881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the VISITAG SURPOINT™ Module With External Processing Unit (EPU) When Used With the THERMOCOOL SMARTTOUCH® SF and the THERMOCOOL SMARTTOUCH® Catheters for Pulmonary Vein Isolation (PVI) (SURPOINT COA)
Lead sponsor
Biosense Webster, Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 4, 2018
Completion date
June 28, 2021
Enrollment
333 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation